BCL2 and neoplasm: On the other hand, an additional target of miR-184, programmed cell death 4 (PDCD4), has been described to be a tumor suppressor by acting at the level of c-Myc and Bcl-2, inhibiting the cell proliferation and survival in nasopharyngeal cancer cells [77].